STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Investment adviser discloses 3.43M Verastem shares in Schedule 13G

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Schedule 13G filing shows investment adviser Logos Global Management LP and affiliates (Logos Global Management GP LLC, Logos Global Master Fund LP, Logos GP LLC and Dr. Arsani William) have accumulated 3,425,000 Verastem (VSTM) common shares, equal to 6.2 % of the 54.95 million shares outstanding as reported on 12 May 2025.

The position is held through Logos Global Master Fund LP. All reporting persons report 0 sole voting/dispositive power and shared voting & dispositive power over the full stake. The stake was acquired in the ordinary course of business; the use of Schedule 13G indicates a passive investment with no intent to influence control. Event date triggering the filing is 21 Jul 2025, and certifications confirm no control-seeking purpose. Each party disclaims group status and beneficial ownership beyond its pecuniary interest.

Positive

  • Institutional investor Logos Global Management disclosed a 6.2 % passive ownership in Verastem, signalling increased professional interest and potential support for the stock.

Negative

  • None.

Insights

TL;DR: 6.2 % passive stake disclosed; modestly positive signal of institutional interest, limited governance impact.

The filing confirms that Logos Global, an institutional investor, now owns more than the 5 % threshold, requiring disclosure. Because the stake is filed on Schedule 13G, it is deemed passive, implying no activist agenda or imminent governance pressure on Verastem. The size—3.43 M shares—makes Logos a top-10 holder and may improve liquidity and market perception, but it does not alter control dynamics (shared voting only). Overall market impact should be modestly constructive, highlighting external confidence while posing minimal strategic risk.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G




Comment for Type of Reporting Person: Percentage calculated based on 54,949,170 shares of Common Stock outstanding on May 12, 2025, as reported in the Form 10-Q filed by the Issuer for the quarter ended March 31, 2025.


SCHEDULE 13G



Logos Global Management LP
Signature:/s/ Arsani William
Name/Title:Managing Partner
Date:07/28/2025
Logos Global Management GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:07/28/2025
Logos Global Master Fund LP
Signature:/s/ Arsani William
Name/Title:Managing Member of Logos GP LLC, General Partner of Logos Global Master Fund LP
Date:07/28/2025
Logos GP LLC
Signature:/s/ Arsani William
Name/Title:Managing Member
Date:07/28/2025
Arsani William
Signature:/s/ Arsani William
Name/Title:Reporting person
Date:07/28/2025

FAQ

Who filed the Schedule 13G for Verastem (VSTM)?

Logos Global Management LP and related entities, including Logos Global Master Fund LP and Dr. Arsani William.

How many Verastem shares does Logos Global own?

The group reports 3,425,000 common shares.

What percentage of Verastem's outstanding stock is represented?

The holding equals 6.2 % of shares outstanding as of 12 May 2025.

Is the stake passive or activist?

Filed on Schedule 13G, the position is classified as passive with no intent to influence control.

Does Logos Global have sole voting power over the shares?

No. It reports 0 sole voting/dispositive power and shared power over all 3.43 M shares.

What event date triggered the filing requirement?

The relevant event date is 21 July 2025 when ownership exceeded 5 %.
Verastem

NASDAQ:VSTM

VSTM Rankings

VSTM Latest News

VSTM Latest SEC Filings

VSTM Stock Data

801.40M
70.82M
0.82%
89.08%
25.94%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEEDHAM